Trademarks & Disclaimers
Registered or registration-pending trademarks of the QIAGEN Group:
QIAGEN®, Sample to Insight®, QIA®, QIA Agent™, QIAamp®, QIAamplifier®, QIAcard®, QIAcube®, QIAcuity®, QIAcuityDx®, QIAEX®, QIAexpress®, QIAgility®, QIAlab®, QIAlink®, QIAmini™ QIAprep®, QIAprep&®, QIAGEN Quality®, QIAquant®, QIAquick®, QIAreach®, QIAscreen®, QIAseq®, QIAsphere®, QIAsprint™, QIAstat-Dx®, QIAsure®, QIAsymphony®, QIAwave® , QIAxcel®, QIAzol®, AllPrep®, Allprotect®, AllTaq®, artus®, AmniSure®, BioRobot®, BiOstic®, Bisulfitome®, BOPP™, careHPV®, Certal®, Cignal®, CLC bio®, CleanStart®, ClearMag®, CLONESAVER®, CompactPrep®, CoralLoad®, CRISPR-Q®, DiagCORE®, digene®, DirectPrep®, DML 3000®, DNeasy®, DyeEx®, EasiCollect®, EASYartus®, Effectene®, EndoFree®, Enzymatics® , EpiTect®, exoEasy™, exoRNeasy™, EZ1®, EZ2®, EZ1&2®, EZ2 Connect™, FastLane®, FastSelect®, FlexiGene®, FlexiTube®, ForenSeq®, FTA®, FusionQuant®, GEDmatch®, GelPilot®, GeneGlobe®, Generation®, GeneSolution®, HC2®, HC2 High-Risk HPV DNA Test®, HiPerFect®, HiSpeed®, HotStarTaq®, Hybrid Capture®, Ingenuity®, InhibitEX®, Inhibitor Removal Technology®, Investigator®, IPA®, ipsogen®, LifeGuard®, LNA®, LoopLigase® , LyseBlue®, MagAttract®, Making improvements in life possible®, MaXtract®, mericon®, MinElute®, miRCURY®, miScript®, MutaQuant®, MutaSearch®, Omniscript®, PartoSure®, PolyFect®, PowerBiofilm®, PowerClean®, PowerFecal®, PowerFood®, PowerLyzer®, PowerMax®, PowerMicrobiome®, PowerPlant®, PowerSoil®, PowerViral®, PowerWater®, Prep&Amp®, ProfileQuant®, Puregene®, Pyro®, Pyrogram®, PyroMark®, Pyrosequencing®, Q-Bond®, Q‑Solution®, qBiomarker®, QCI®, QFM®, QFT®, Qproteome®, QuantiFast®, QuantiFERON®, QuantiFERON Monitor®, QuantiNova®, Quantiscript®, Quantiplex®, QuantiTect®, Rapid Capture®, REPLI-g®, RNAprotect®, RNeasy®, Rotor-Disc®, Rotor-Gene®, Rotor-Gene AssayManager®, RT²®, RT² Profiler®, Saltonase™, Scorpions®, ScreenClust®, ScreenGel®, Sensiscript®, SensiPhi®, SpinClean®, StableScript®, STM®, SuperFect®, SwiftMag®, T-Script®, therascreen®, TissueRuptor®, TopTaq®, Transfac®, TurboCapture®, TurboFilter®, Type-it®, UltraClean®, UltraRun®, UltraSens®, Uni-Core®, Vapor-Lock®, VeraSeq®, Verogen®, WarmX®, ZIPSCRIPT®.
Other trademarks
2D Matrix® (Thermo Fisher Scientific or its subsidiaries); Abbott® (Abbott Laboratories); Abbott RealTime® (Abbott Laboratories); ABgene® (Thermo Fisher Scientific or its subsidiaries); ABI 5500 SOLiD™ (Life Technologies Corporation); ABI PRISM® (Life Technologies Corporation); Affymetrix® (Affymetrix, Inc.); Agilent® (Agilent Technologies, Inc.); Air-Mate™ (3M); ÄKTA® (GE Healthcare); Alexa Fluor® (Life Technologies Corporation); Amgen® (Amgen, Inc.); AmpFlstr® (Life Technologies Corporation); Apple® (Apple Computer, Inc.); Applied Biosystems® (Life Technologies Corporation); APTIMA® (Gen-Probe Incorporated); ATCC® (American Type Culture Collection); Avastin® (Genentech, Inc.); bactotype® (Indical Bioscience GMBH); BD™ (Becton Dickinson and Company); Benzonase® (Merck KGaA, Darmstadt, Germany); BigDye™ (Life Technologies Corporation); BioLogic™ (Bio-Rad Laboratories, Inc.); BioMag® (Polysciences Inc.); Bio-One® (Greiner Bio-One GmbH; Bio-Rad® (Bio-Rad Laboratories, Inc.); Bluetooth® (Blootooth SIG, Inc.); CDP-Star® (Life Technologies Corporation); CEQ™ (Beckman Coulter, Inc.); CLART® (Genomica S.A.U. Sociedad Anònima Unipersonal); cobas® (Roche Diagnostics Operations, Inc.); Coomassie® (ICI [Imperial Chemical Industries] Organics Inc.); Copan® (Copan Italia S.P.A.); Corning® (Corning, Inc.); CryoTube® (Thermo Fisher Scientific or its subsidiaries); Cy® (GE Healthcare); DACRON® (Invista North America S.A.R.L. Corporation); DAPase™ (UNIZYME); DART™ (Genome Diagnostics); DeepWell™ (Thermo Fisher Scientific or its subsidiaries); DYEnamic™ (GE Healthcare); EasyXtal® (Molecular Dimensions, Inc.); eNAT™ (Copan Italia S.P.A.); eppendorf twin.tec® (Eppendorf AG); Eppendorf® (Eppendorf AG); ERBITUX® (ImClone LLC., a wholly-owned subsidiary of Eli Lilly and Company); Excel® (Microsoft Corporation); FACS® (Becton Dickinson and Company); Falcon® (Corning, Inc.); FAM™ (Life Technologies Corporation); FPLC® (GE Healthcare); GeneAmp® (Life Technologies Corporation); GeneChip® (Affymetrix, Inc.); GeneMapper® (Life Technologies Corporation); GeneScan® (Life Technologies Corporation); Genotyper® (Life Technologies Corporation); GILOTRIF® (Boehringer Ingelheim International GmbH); Hard-Shell® (Bio-Rad Laboratories, Inc.); Helix®, Helix logo (Helix Inc.); HiSeq® (Illumina, Inc.); Horizon™ (Horizon Discovery Limited); iCycler iQ® (Bio-Rad Laboratories, Inc.); Identifiler® (Life Technologies Corporation); llumina® (Illumina, Inc.); Infinium® (Illumina, Inc.); Internet Explorer® (Microsoft Corporation); Ion PGM™ (Life Technologies Corporation); Ion Torrent™ (Life Technologies Corporation); iPad® (Apple Computer, Inc.); iPod nano® (Apple Computer, Inc.); iPod® (Apple Computer, Inc.); IRESSA® (AstraZeneca Group); iSeq® (Illumina, Inc.); J&J® (Johnson & Johnson); JOE™ (Life Technologies Corporation); K-Y® (Johnson & Johnson); KAPA® (Roche Group); KAPA Biosystems® (Roche Group); LIAISON® (DiaSorin); LightCycler® (Roche Group); Luminex® (Luminex Corporation); LYNPARZA® (Astra Zeneca Group); LyoSphere™ (BioLyph Inc.); LyoSpheres™ (BioLyph Inc.); March of Dimes® (March of Dimes Foundation) ; Mastercycler® (Eppendorf AG); MegaBACE™ (GE Healthcare); Merck® (Merck Sharp & Dohme Corp.); Merz® (Merz Pharma GmbH & Co. KGaA); MethylScreen™ (Orion Genomics, LLC); Metrogel® (Galderma S.A.); MGB™ (Epoch Biosciences); MicroAmp® (Life Technologies Corporation); Microgard™ (Becton Dickinson and Company); Micronic™ (Micronic Holding B.V.); Microsoft® (Microsoft Corporation); Microtainer® (Becton Dickinson and Company); MiniSeq® (Illumina, Inc.); MiSeq® (Illumina, Inc.); Monistat® (Johnson & Johnson); MVS® (Artel, Inc.); Mx3005P® (Stratagene); MyChoice® (Myriad Genetics, Inc.); MyChoice® CDx (Myriad Genetics, Inc.); Myriad Genetics® (Myriad Genetics, Inc.); Myriad Genetics® logo (Myriad Genetics, Inc.); Nanosep® (Pall Corporation); NASBA® (Organon Teknika); National Comprehensive Cancer Network® (National Comprehensive Cancer Network); NCCN® (National Comprehensive Cancer Network); NEB® (New England Biolabs, Inc.); NEBNext® (New England Biolabs, Inc.); New England Biolabs® (New England Biolabs, Inc.); NeXtal® (Molecular Dimensions, Inc.); NextSeq® (Illumina, Inc.); Norforms® (C.B. Fleet Investment Corporation); NovaSeq® (Illumina, Inc.); Nunc® (Thermo Fisher Scientific or its subsidiaries); Opera™ (Evotec Technologies); Oragene® (DNA Genotek Inc., a subsidiary of OraSure Technologies, Inc.); PAXgene® (PreAnalytiX GmbH); pBluescript® (Stratagene); pGAPase™ (UNIZYME); PIPETMAN® (Gilson Inc.); PIQRAY® (Novartis AG); PPT™ (Becton Dickinson and Company); PrepStain® (Becton Dickinson and Company); PreservCyt® (Hologic, Inc.); Primer Express® (Life Technologies Corporation); Puritan® (Puritan Medical Products Company); Qcyclase™ (UNIZYME); Remp® (Remp AG); RespiFinder® (PathoFinder BV); Ribo-Zero® (Illumina, Inc.); Roche® (Roche Group); Sarstedt® (Sarstedt AG and Co.); Schering-Plough® (Merck Sharp & Dohme Corp.); Siemens® (Siemens AG); sign® (Diatech srl); S-Monovette® (Sarstedt AG and Co.); SNaPshot™ (Life Technologies Corporation); SSP™ (Olerup SSP AB Company, Sweden); Starlab® (Starlab Group); SurePath® (Becton Dickinson and Company); SYBR® (Life Technologies Corporation); TaqMan® (Roche Group); Teflon® (E. I. du Pont de Nemours and Company); Terumo® (Terumo Europe N.V.); Thermo Scientific® (Thermo Fisher Scientific or its subsidiaries); Thermo-Fast® (Thermo Fisher Scientific or its subsidiaries); ThinPrep® (Hologic, Inc.); TRACKMAN® (Gilson Inc.); TraXis® (Micronic Holding B.V.); TruSeq® (Illumina, Inc.); Tubersol® (Sanofi Pasteur Ltd.); Vacuette® (Greiner Bio-One GmbH); Vacutainer® (Becton Dickinson and Company); Vagisan™ (Dr. August Wolff, GmbH & Co. KG Arzneimittel); Vagisil® (Combe Incorporated); Vectibix® (Immunex Corporation); Venoject® (Terumo Europe N.V.); Venosafe® (Terumo Europe N.V.); VEROGEN® (Verogen Inc.); Vertex® (Vertex Pharmaceuticals Incorporated); VIC® (Life Technologies Corporation); virotype® (Indical Bioscience GMBH); Whatman® (Whatman International Limited Corporation); Windows® (Microsoft Corporation); Yeast Gard® (TCF National Bank). All other trademarks are the property of their respective owners.
Disclaimers
Registered names, trademarks, etc. used in the QIAGEN website, even when not specifically marked as such, are not to be considered unprotected by law.
External links on this web site are provided only for the convenience of QIAGEN web site visitors. QIAGEN has no interest in, responsibility for, or control over non-QIAGEN affiliated linked sites. QIAGEN makes no promises or warranties of any kind, express or implied, including those of merchantability and fitness for a particular purpose, as to content of linked sites. In no event shall QIAGEN be liable for any damages resulting from use of these links even if QIAGEN has been informed of the possibility of such liability.
NOTICE TO PURCHASER: LIMITED LICENCE
'Black Hole Quencher,' 'BHQ', 'CAL Fluor', and Quasar are registered trademarks of Biosearch Technologies, Inc.. Novato, CA. Quasar dyes are subject to US Patent 7,705,150.
QIAGEN products incorporating the BHQ, CAL Fluor, and Quasar dyes are licensed and sold under agreement with Biosearch Technologies, lnc.
These products are sold for use by the end-user only and may not be re-sold, distributed or repackaged except for authorized OEM Customers.
The PAXgene Blood RNA System (cat. nos. 762105, 762115, 762331, and 762134) and the PAXgene Blood DNA System (cat. nos. 761105, 761115, 761125, 761132, and 761133) are for research use only and not for use in diagnostic procedures.
The PAXgene Blood RNA Kit (cat. nos. 762164 and 762174) is for in vitro diagnostic use. Not available in all countries.
The PAXgene Blood RNA MDx Kit (cat. no. 762461) is intended as a general-purpose device for laboratory use. No claim or representation is intended for its use to identify any specific organism or for clinical use (diagnostic, prognostic, therapeutic, or blood banking). It is the user’s responsibility to validate the performance of the PAXgene Blood RNA MDx Kit for any particular use, since the performance characteristics of these kits have not been validated for any specific organism. The performance characteristics of this product have not been fully established.
HGMD® is a registered trademark of Cardiff University.
For products comprising SYBR Green:
This product is provided under an intellectual property license from Life Technologies Corporation. The sale of this product is expressly conditioned on the buyer using the product or its components only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, 5791 Van Allen Way, Carlsbad, CA 92008 USA or outlicensing@lifetech.com.
For nucleic acid amplification products containing dUTP:
The use of this product is covered by at least one claim of U.S. Patent No. 7,687,247 owned by Life Technologies Corporation. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The buyer cannot sell or otherwise transfer (a) this product, (b) its components, or (c) materials made by the employment of this product or its components to a third party or otherwise use this product or its components or materials made by the employment of this product or its components for Commercial Purposes. Commercial Purposes means any activity for which a party receives or is due to receive consideration and may include, but is not limited to: (1) use of the product or its components in manufacturing; (2) use of the product or its components to provide a service, information, or data; (3) use of the product or its components for therapeutic, diagnostic or prophylactic purposes; or (4) resale of the product or its components, whether or not such product or its components are resold for use in research. The buyer cannot use this product or its components or materials made using this product or its components for therapeutic, diagnostic or prophylactic purposes. Further information on purchasing licenses under the above patents may be obtained by contacting the Licensing Department, Life Technologies Corporation, 5791 Van Allen Way, Carlsbad, CA 92008. Email: outlicensing@lifetech.com.
Rotor-Gene Q
For applicable countries:
The purchase of this product includes a limited, non-transferable license to one or more of U.S. Patent Applications Nos. 2003-0224434 and 2006- 0019253 and all continuations and divisionals, and corresponding claims in patents and patent applications outside the United States, owned by the University of Utah Research Foundation, Idaho Technology, Inc., and/or Roche Diagnostics GmbH, for internal research use or for non-in vitro diagnostics applications. No right is conveyed, expressly, by implication or estoppel, for any reagent or kit, or under any other patent or patent claims owned by the University of Utah Research Foundation, Idaho Technology, Inc., and/or Roche Diagnostics GmbH, or by any other Party. For information on purchasing licences for in-vitro diagnostics applications or reagents, contact Roche Molecular Systems, 4300 Hacienda Drive, Pleasanton, CA 94588, USA.
Rotor-Gene Q MDx
For applicable countries:
The purchase of this product includes a limited, non-transferable license to one or more of U.S. Patent Application Nos. 2003-0224434 and 2006-0019253, and PCT Patent Application No. WO 2007/035806, and all continuations and divisionals, and corresponding claims in patents and patent applications outside the United States, owned by the University of Utah Research Foundation, Idaho Technology, Inc., Evotec Biosystems GmbH, and/or Roche Diagnostics GmbH for human or animal in-vitro diagnostics only. No right is conveyed, expressly, by implication or estoppel, for any reagent or kit, or under any other patent or patent claims owned by the University of Utah Research Foundation, Idaho Technology, Inc., Roche Diagnostics GmbH, or by any other Party. This product may be operated only with authorized reagents such as fully licensed QIAGEN kits and assays. For information on purchasing licenses for in-vitro diagnostics applications or reagents, please contact Roche Molecular Systems, 4300 Hacienda Drive, Pleasanton, CA 94588, USA.
QIAcuity dPCR instruments, consumables, and assays
QIAcuity Digital PCR instruments are sold under license from Bio-Rad Laboratories, Inc. and exclude rights for use with pediatric applications.
QIAcuity consumables and assays are sold under license from Bio-Rad Laboratories, Inc. for use on QIAcuity Digital PCR instruments and exclude rights for use with pediatric applications.
QuantiFERON-TB Gold Plus
QuantiFERON-TB Gold Plus (QFT-Plus) is an in vitro diagnostic aid for detection of Mycobacterium tuberculosis infection. QFT-Plus is an indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assessment, radiography, and other medical and diagnostic evaluations. QFT-Plus package inserts, up-to-date licensing information and product-specific disclaimers can be found at www.qiagen.com.
For products comprising EvaGreen:
The purchase price of this product includes a limited, nontransferable immunity from suit under U.S. Patent Nos. US7,803,943 B2, US7,776, 567B2, and corresponding patent claims outside of the United States, to use solely for the buyer's own internal use (whether the buyer is an academic or for-profit entity) and commercial services.